Invivyd

#Covid-19 #Covid-19 treatment #FDA #Invivyd #Monoclonal antibodies

FDA approves Covid-19 mAb for emergency use

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) to half-life extended monoclonal antibody (mAb) Pemgarda (pemivibart, or VYD222) for the pre-exposure prophylaxis (prevention) of Covid-19. It is approved in adults and adolescents (12 years of age and older weighing at least… Read More

#News